[{"Name": "FundyLongShort", "Time": "20181114", "Text": "@LibertyRPF That's outstanding."}, {"Name": "Carl_C_Icahn", "Time": "20181114", "Text": "Just issued statement regarding $DVMT transaction rumors (including other important information): https://t.co/S9lub7Uc0K"}, {"Name": "Carl_C_Icahn", "Time": "20181115", "Text": "Just issued statement regarding $DVMT amended deal (including other important information): https://t.co/LfcbUJkC1v"}, {"Name": "FundyLongShort", "Time": "20181116", "Text": "@ShortSightedCap A city and region in secular decline...unless they make massive changes."}, {"Name": "TMTanalyst", "Time": "20181117", "Text": "@oknotsomuch Where to begin?  Gougeres, salmon rillettes, bakes Brie and devils on horseback to start. Butternut sq\u2026 https://t.co/Eb1WZSu1fM"}, {"Name": "TMTanalyst", "Time": "20181117", "Text": "@oknotsomuch A turducken and a fried turkey with gravy!!!!"}, {"Name": "TMTanalyst", "Time": "20181117", "Text": "@oknotsomuch And for sides; duck fat roasted potatoes, mashed sweet potatoes with a prailine topping, harissa roast\u2026 https://t.co/pyyEZtWvzF"}, {"Name": "TMTanalyst", "Time": "20181117", "Text": "@oknotsomuch I\u2019ll start making stock this Sunday. Other people will bring dessert. And drinking some good wine. Not sure what yet."}, {"Name": "CitronResearch", "Time": "20181119", "Text": "$NIO much more than the \"Chinese Tesla\".  Absurd short interest ignores the compelling product and patient investor\u2026 https://t.co/qKWOd60nnL"}, {"Name": "CopperfieldRscr", "Time": "20181119", "Text": "Kudos to @SEC_Enforcement for charging the former CFO of $BBSI with accounting fraud, which marks the 4th company w\u2026 https://t.co/WNKYrB7Ti4"}, {"Name": "CopperfieldRscr", "Time": "20181119", "Text": "Last Friday (11/16) after most were gone for the weekend, $TCX published its Q&amp;A script for Q3'18. After withholdin\u2026 https://t.co/NNzwPjGGce"}, {"Name": "CopperfieldRscr", "Time": "20181119", "Text": "As we documented at length in our first report (https://t.co/M8bV6t94yY), $TCX has consistently made aggressive, re\u2026 https://t.co/sTOzDswNmr"}, {"Name": "CopperfieldRscr", "Time": "20181119", "Text": "Alas, last Friday, $TCX again misrepresented a historical metric to flatter/minimize another deteriorating metric -\u2026 https://t.co/r3zxhK3CvY"}, {"Name": "CopperfieldRscr", "Time": "20181119", "Text": "On its Q3'17 Call, $TCX management stated churn was 2.49% excluding RP. However, with churn now spiking to 3.03%, m\u2026 https://t.co/cuLSUEMYou"}, {"Name": "CopperfieldRscr", "Time": "20181119", "Text": "By changing the compare to 2.82% from 2.49%, $TCX management makes the YoY compare with monthly churn of 3.03% appe\u2026 https://t.co/j0pRIxpp7Z"}, {"Name": "CopperfieldRscr", "Time": "20181119", "Text": "In a vacuum, this $TCX misrepresentation may appear immaterial, however, as carefully documented, accounting gimmic\u2026 https://t.co/uGClmMVz8s"}, {"Name": "CitronResearch", "Time": "20181120", "Text": "Citron buys $NVDA.  This is the first time in 2 years stock offers an appealing risk-reward to investors.  $NVDA st\u2026 https://t.co/r2FrdRZEFE"}, {"Name": "CitronResearch", "Time": "20181126", "Text": "$MNK has just FAILED it's only real clinical trial of Acthar. Mallinckrodt has failed to disclose.  Citron will fol\u2026 https://t.co/bss1GLKJ3i"}, {"Name": "CitronResearch", "Time": "20181126", "Text": "$MNK failed clinical studies comes weeks after OIG publishes that Acthar is a drug based on a history of \"fraud and\u2026 https://t.co/z0ZoLZXbca"}, {"Name": "FundyLongShort", "Time": "20181128", "Text": "@Nonrelatedsense He definitely seems insufferable."}]